![Mark Glickman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Glickman
Director/Board Member at
METAVIA INC.
Net worth: 29 109 $ as of 2026-09-29
Profile
Mr. Mark A. Glickman is an Independent Director at BioStem Technologies, Inc., a President & Chief Executive Officer at BioFlorida, Inc. and an Independent Director at MetaVia, Inc. He is on the Board of Directors at BioStem Technologies, Inc., Otsuka Precision Health, Inc. and MetaVia, Inc. Mr. Glickman was previously employed as a Co-CEO & Chief Business Officer by TherapeuticsMD, Inc., a Chief Commercial Officer by Esperion Therapeutics, Inc., a Chief Commercial Officer by POZEN, Inc., a Chief Commercial Officer by Aralez Pharmaceuticals, Inc., a Senior Vice President-Sales by Auxilium Pharmaceuticals LLC, a Vice President-Medical Device Division by Otsuka America Pharmaceutical, Inc., a Senior Vice President-Sales & Marketing by Oscient Pharmaceuticals Corp., a Marketing Director & Vice President-Sales by KOS Pharmaceuticals, Inc., a General Manager-Sales by Baxter Healthcare Corp., and a Vice President-Sales by Bayer HealthCare /Diabetes Care Division/.
He received his undergraduate degree from State University of New York College at Oswego and an MBA from Nyu Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-26 | 7,671 ( 0.04% ) | 23 703 $ | 2026-09-29 | |
METAVIA INC. 0.05% | 2026-06-07 | 3,443 ( 0.05% ) | 5 406 $ | 2026-09-29 |
Mark Glickman active positions
| Companies | Position | Start |
|---|---|---|
| METAVIA INC. | Director/Board Member | 2023-05-10 |
| BIOSTEM TECHNOLOGIES, INC. | Director/Board Member | 2026-06-04 |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Chief Executive Officer | 2023-12-08 |
Former positions of Mark Glickman
| Companies | Position | End |
|---|---|---|
| THERAPEUTICSMD, INC. | Chief Executive Officer | 2022-12-31 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-10 |
| OLD API WIND-DOWN LTD. | Corporate Officer/Principal | 2018-03-29 |
| POZEN INC. | Corporate Officer/Principal | 2016-01-31 |
| AUXILIUM PHARMACEUTICALS, INC. | Sales & Marketing | 2015-02-28 |
Education of Mark Glickman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
State University of New York College at Oswego
 State University of New York College at Oswego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare /Diabetes Care Division/
 Bayer HealthCare /Diabetes Care Division/ Medical DistributorsDistribution Services Provides diabetes care products | Distribution Services |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Commercial Services |
BioStem Technologies, Inc.
 BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
TherapeuticsMD, Inc.
 TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Mark Glickman
